Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment

OncoImmunology

Volumn 4, Issue 6, 2015, Pages

  Ridder, Kirsten ^a   Sevko, Alexandra ^b   Heide, Janina ^a   Dams, Maria ^a   Rupp, Anne Kathleen ^c   Macas, Jadranka ^a   Starmann, Julia ^c   Tjwa, Marc ^a   Plate, Karl H ^a   S�ltmann, Holger ^c   Altevogt, Peter ^c   Umansky, Viktor ^b   Momma, Stefan ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Carcinoma; Cre Lox; Exosomes; Extracellular vesicles; Glioma; Immunosuppression; MDSCs; miRNA

Indexed keywords

MICRORNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; EXOSOME; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; GENETIC RECOMBINATION; IMMUNOCYTOCHEMISTRY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUCROSE GRADIENT; TUMOR MICROENVIRONMENT; ULTRACENTRIFUGATION;

EID: 84944463735     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1008371     Document Type: Article

References (33)

1. Hanahan D, Weinberg R. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j. cell.2011.02.013
2. Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno, G, Hergueta-Redondo M, Williams C, Garc�a-Santos G, Ghajar CM et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18(6):883-91; PMID:22635005; http://dx. doi.org/10.1038/nm.2753
3. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M, Wrana JL. Exosomes mediate stromalmobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012; 151:1542-56; PMID:23260141; http://dx.doi.org/10.1016/j.cell.2012.11.024
4. Filipazzi P, B�rdek M, Villa A, Rivoltini L, Huber V. Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol 2012; 22:342-9; PMID:22369922; http:// dx.doi.org/10.1016/j.semcancer.2012.02.005
5. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007; 67:2912-5; PMID:17409393; http://dx.doi.org/10.1158/0008-5472.CAN-07-0520
6. Valadi H, Ekstr�m K, Bossios A, Sj�strand M, Lee JJ, L�tvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-9; PMID:17486113; http://dx.doi.org/10.1038/ncb1596
7. Skog J, W�rdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT, Carter BS, Krichevsky AM, Breakefield XO. Glioblastomamicrovesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10:1470-6; PMID:19011622; http://dx.doi.org/ 10.1038/ncb1800
8. Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, Bond VC, Borr�s FE, Breakefield X, Budnik V et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 2012; 10:e1001450; PMID:23271954; http://dx.doi.org/10.1371/journal.pbio.1001450
9. Rak J, Guha A. Extracellular vesicles-vehicles that spread cancer genes. Bioessays 2012; 34:489-97; PMID:22442051; http://dx.doi.org/10.1002/ bies.201100169
10. Ridder K, Keller S, Dams M, Rupp A-K, Schlaudraff J, Turco DD, Starmann J, Macas J, Karpova D, Devraj K et al. Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol 2014; 12:e1001874; PMID:24893313; http://dx.doi.org/ 10.1371/journal.pbio.1001874
11. Weissenberger J, Steinbach JP, Malin G, Spada S, R�licke T, Aguzzi A. Development and malignant progression of astrocytomas in GFAP-v-srctransgenic mice. Oncogene 1997; 14:2005-13; PMID:9160879; http://dx.doi.org/10.1038/sj.onc.1201168
12. Pohl U, Wick W, Weissenberger J, Steinbach JP, Dichgans J, Aguzzi A, Weller M. Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murineglioma cell lines. Int J Oncol 1999; 15:829-34; PMID:10493969; http://dx.doi.org/ 10.3892/ijo.15.4.829
13. Keller S, Ridinger J, Rupp A-K, Janssen JWG, Altevogt P. Body fluid derivedexosomes as a novel template for clinical diagnostics. J Transl Med 2011; 9:86; PMID:21651777; http://dx.doi.org/10.1186/1479-5876-9-86
14. Th�ry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006; Chapter 3:Unit 3.22; PMID:18228490; http://dx.doi.org/10.1002/0471143030.cb0322s30
15. Keller S, K�nig A-K, Marm� F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett 2009; 278:73-81; PMID:19188015; http://dx.doi.org/ 10.1016/j.canlet.2008.12.028
16. Gu H, Zou YR, Rajewsky K. Independent control of immunoglobulin switchrecombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 1993; 73:1155-64; PMID:8513499; http://dx.doi.org/10.1016/0092-8674(93)90644-6
17. Schwenk F, Sauer B, Kukoc N, Hoess R, M�ller W, Kocks C, K�hn R, Rajewsky K. Generation of Cre recombinase-specific monoclonal antibodies, able to characterize the pattern of Cre expression in cretransgenic mousestrains. J Immunol Methods 1997; 207:203-12; PMID:9368647; http://dx.doi.org/ 10.1016/S0022-1759(97)00116-6
18. Mignot G, Roux S, Thery C, S�gura E, Zitvogel L. Prospects for exosomes inimmunotherapy of cancer. J Cell Mol Med 2006; 10:376-88; PMID:16796806; http://dx. doi.org/10.1111/j.1582-4934.2006.tb00406.x
19. Thery C, Duban L, Segura E, Veron P, Lantz O, Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 2002; 3:1156-62; PMID:12426563; http://dx.doi.org/ 10.1038/ni854
20. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation ofmyeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175
21. Topalian SL, Drake CG, Pardoll DM. Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity. Curr Opin Immunol. 2012; 24:207-12; PMID:22236695; http://dx.doi.org/10.1016/j. coi.2011.12.009
22. Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, Bronte V, ChouaibS. PD-L1 is a novel direct target of HIF-1a, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med 2014; 211:781-90; PMID:24778419; http://dx. doi.org/10.1084/jem.20131916
23. Fife BT, Pauken KE, Eagar TN, Obu T, Wu J, Tang Q, Azuma M, Krummel MF, Bluestone JA. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol 2009; 10:1185-92; PMID:19783989; http://dx.doi. org/10.1038/ni.1790
24. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linkinginflammation and cancer. J Immunol 2009; 182:4499-506; PMID:19342621; http://dx. doi.org/10.4049/jimmunol.0802740
25. Okada H, Kohanbash G, Lotze MT. MicroRNAs in immune regulation-opportunities for cancer immunotherapy. Int J Biochem Cell Biol 2010; 42:1256-61; PMID:20144731; http://dx.doi.org/10.1016/j. biocel.2010.02.002
26. Bronisz A, Godlewski J, Wallace JA, Merchant AS, Nowicki MO, Mathsyaraja H, Srinivasan R, Trimboli AJ, Martin CK, Li F et al. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol 2012; 14:159-67; PMID:22179046; http://dx.doi.org/10.1038/ncb2396
27. Jin L, Wessely O, Marcusson EG, Ivan C, Calin GA, Alahari SK. Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-a in breast cancer. Cancer Res 2013; 73:2884-96; PMID:23338610; http://dx.doi.org/10.1158/0008-5472.CAN-12-2162
28. Van der Auwera I, Limame R, van Dam P, Vermeulen PB, Dirix LY, Van LaereSJ. Integrated miRNA and mRNA expression profiling of the inflammatorybreast cancer subtype. Br J Cancer 2010; 103:532-41; PMID:20664596; http://dx.doi.org/10.1038/sj. bjc.6605787
29. Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, Eisele G, Weller M, Keller A. A specific miRNA signature in the peripheral blood of glioblastomapatients. J Neurochem 2011; 118:449-57; PMID:21561454; http://dx.doi.org/10.1111/j.1471-4159.2011.07307.x
30. Webber J, Clayton A. How pure are your vesicles? J Extracell vesicles 2013; 2:1-6; PMID: 24009896; http://dx.doi.org/10.3402/jev.v2i0.19861
31. Jeppesen DK, Hvam ML, Primdahl-Bengtson B, Boysen AT, Whitehead B, Dyrskj�t L, Orntoft TF, Howard KA, Ostenfeld MS. Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J Extracell vesicles 2014; 3:25011; PMID:25396408; http://dx.doi.org/10.3402/jev. v3.25011
32. Rupp A-K, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marm� F, S�ltmann H, Altevogt P. Loss of EpCAM expression in breast cancerderived serum exosomes: role of proteolytic cleavage. Gynecol Oncol 2011; 122:437-46; PMID:21601258; http://dx.doi.org/10.1016/j.ygyno.2011.04.035
33. Riedle S, Kiefel H, Gast D, Bondong S, Wolterink S, Gutwein P, Altevogt P. Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity. Biochem J 2009; 420:391-402; PMID:19260824; http://dx.doi.org/10.1042/BJ20081625